organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoIUCrDATA
ISSN: 2414-3146

5-Cyclo­propyl-1-[(4-methyl­benzene)­sulfon­yl]indole-2-carbaldehyde

crossmark logo

aDepartment of Chemistry, REVA University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore 560064, Karnataka, India, bTeadus Pharma, Plot No. 3B, Type-1, Sy. No.386, TSIIC Industrial Estate, Prashanth Nagar, Kukatpally, Hyderabad 500072, Telangana, India, cDepartment of Biotechnology, Sharda School of Bio-Science & Technology, Sharda University, Greater Noida, India, dCentre for Bio-Organic Chemistry, REVA Research Centre, REVA University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore 560064, Karnataka, India, and eDepartment of Chemistry, Wright State University, 3640 Colonel Glenn Hwy., Dayton, OH 45435, USA
*Correspondence e-mail: [email protected]

Edited by I. Brito, University of Antofagasta, Chile (Received 3 September 2026; accepted 4 September 2026; online 15 September 2026)

The crystal structure of the title compound, C19H17NO3S, was determined by single-crystal X-ray diffraction. The compound crystallizes in the monoclinic crystal system with space group P21/c. The indole ring is essentially planar, with cyclo­propyl, aldehyde and p-toluene­sulfonyl groups attached at the C5, C2 and N1 positions, respectively. The aldehyde substituent is nearly coplanar with the indole ring, while the cyclo­propyl and p-tolyl rings are almost perpendicular to it. The crystal packing is mainly influenced by slipped π–π stacking inter­actions, along with weak C—H⋯O inter­actions involving the sulfonyl oxygen atoms. Hirshfeld surface analysis shows that H⋯H (46.6%), O⋯H/H⋯O (23.5%), C⋯H/H⋯C (16.0%) and C⋯C (8.0%) contacts make the major contributions to the crystal packing.

3D view (loading...)
[Scheme 3D1]
Chemical scheme
[Scheme 1]

Structure description

Indole derivatives continue to attract considerable attention because of their diverse biological activities and their widespread occurrence in natural products and therapeutic agents (Sundberg, 2012View full citation; Gribble, 2016View full citation; Kumar et al., 2022View full citation). Owing to their structural versatility, indole-based compounds have become privileged scaffolds in medicinal chemistry, and structural modification of the groups attached to the indole nucleus can influence mol­ecular conformation, inter­molecular inter­actions and physicochemical properties (Sravanthi & Manju, 2016View full citation; Zeng et al., 2024View full citation; Yang et al., 2026View full citation; Drăgoi et al., 2026View full citation). Among indole-incorporated small organic mol­ecules (SOMs), those containing a cyclo­propane ring have attracted attention for tuning the ADMET properties of drug candidates (Foote et al., 2013View full citation; Tran & Henary, 2022View full citation; Hassam et al., 2012View full citation). In view of the inter­est in cyclo­propyl- and indole-containing SOMs, we determined the solid-state structure of the title compound (Fig. 1[link]) and describe its structural features here.

[Figure 1]
Figure 1
Mol­ecular structure of the title compound showing the atom-numbering scheme with displacement ellipsoids drawn at the 50% probability level

The mol­ecular structure of the title compound is shown in Fig. 2[link]. The compound crystallizes in the monoclinic space group P21/c, with one mol­ecule in the asymmetric unit. The mol­ecule consists of an indole ring substituted by a cyclo­propyl group at the C5 position, an aldehyde group at C2, and a p-toluene­sulfonyl (tos­yl) group attached to atom N1. The indole ring system is essentially planar with an r.m.s. deviation of 0.019 Å, whereas the overall mol­ecular conformation is non-coplanar because of the orientation of the substituent groups. The sulfur atom adopts the expected distorted tetra­hedral geometry, being coordinated by two oxygen atoms, one nitro­gen atom and one carbon atom. The S1—O1 [1.421 (2) Å], S1—O2 [1.422 (2) Å] and S1—N1 [1.684 (3) Å] bond lengths are typical of aromatic sulfonamide derivatives. Likewise, the widened O1—S1—O2 angle of 120.73 (15)° is characteristic of sulfonyl-containing compounds and is consistent with the geometry commonly observed for aromatic sulfonamides.

[Figure 2]
Figure 2
Mol­ecular structure of title compound showing the intra­molecular weak C—H⋯O inter­actions involving the sulfonyl oxygen atoms, which contribute to conformational stabilization. The atomic labelling scheme is shown for clarity.

Least-squares plane analysis shows that the aldehyde group is nearly coplanar with the indole ring system, with a dihedral angle of 3.1 (4)°. In contrast, the cyclo­propyl and p-tolyl rings are oriented nearly perpendicular to the indole plane, with dihedral angles of 87.0 (3) and 84.49 (9)°, respectively. The cyclo­propyl ring shows the expected angular compression associated with a strained three-membered ring. The torsion angles about the N-sulfonyl linkage [S1—N1—C6—C13 = −169.3 (2)° and S1—N1—C15—C14 = 169.2 (2)°] indicate an extended conformation of the N-sulfonyl group. In the crystal structure (Fig. 3[link]), no classical hydrogen bonds are present because the mol­ecule lacks N—H and O—H donor groups. Instead, the crystal packing involves weak C—H⋯O inter­actions, with the sulfonyl oxygen atoms acting as acceptors, together with slipped π–π stacking inter­actions between neighbouring aromatic rings [Cg1⋯Cg2 = 3.9655 (18) Å, perpendicular distance = 3.627 Å, interplanar angle = 1.10° and slippage = 1.603 Å and Cg3⋯Cg4 = 3.7798 (18) Å, perpendicular distance = 3.576 Å, interplanar angle = 0.02° and slippage = 1.223 Å where Cg1 and Cg2 are the centroids of the C7–C10/C18/C19 ring and its syemmetry-generated counterpart at (x, Mathematical equation − y, −Mathematical equation + z) and Cg2 and Cg3 are the centroids of the C3–C6/C12/C13 ring and its symmetry-generated counterpart at (1 − x, −y, −z)].

[Figure 3]
Figure 3
Crystal packing of the title compound showing significant slipped π–π stacking inter­actions between neighboring aromatic rings contributing to supra­molecular assembly and mol­ecular packing [centroid–centroid distances Cg1⋯Cg2 = 3.9655 (18) and Cg3⋯Cg4 = 3.7798 (18) Å where Cg1 and Cg2 are the centroids of the C7–C10/C18/C19 ring and its syemmetry-generated counterpart at (x, Mathematical equation − y, −Mathematical equation + z) and Cg2 and Cg3 are the centroids of the C3–C6/C12/C13 ring and its symmetry-generated counterpart at (1 − x, −y, −z)]. Hydrogen atoms are omitted for clarity.

The inter­molecular contacts were further analysed using Hirshfeld surface analysis. The dnorm surface (Fig. 4[link]) shows prominent red regions corresponding to close C—H⋯O contacts, while the shape-index surface indicates slipped π–π stacking inter­actions. The corresponding two-dimensional fingerprint plots (Fig. 5) show that H⋯H contacts contribute 46.6% to the Hirshfeld surface, followed by O⋯H/H⋯O (23.5%), C⋯H/H⋯C (16.0%) and C⋯C (8.0%). These contacts represent the major contributions to the crystal packing.

[Figure 4]
Figure 4
Hirshfeld surface analysis of title compound showing (a) dnorm surface highlighting close inter/intra mol­ecular contacts as red patches, (b) shape-index map illustrating complementary red and blue triangular regions associated with slipped aromatic π–π stacking inter­actions and (c) curvedness surface showing flat aromatic regions characteristic of stacking inter­actions

A comparison with the related structure of 3-methyl-1-tosyl-1H-indole-2-carbaldehyde (Pradeep et al., 2013View full citation) shows that both compounds have a non-coplanar arrangement associated with the N-tosyl substituent. However, the title compound adopts a more extended conformation about the N-sulfonyl linkage, which may be associated with the presence of the cyclo­propyl substituent at the C5 position. Although N-tosyl cyclo­propyl-substituted indole derivatives have been reported in the patent literature (World Intellectual Property Organization, 2011View full citation), closely related crystal structures have not been reported. The present structure therefore adds to the available crystallographic data for cyclo­propyl-substituted N-tosyl indole derivatives.

Synthesis and crystallization

Ethyl 5-cyclo­propyl-1-tosyl-1H-indole-2-carbox­ylate (5.0 g, 13.03 mmol) was dissolved in 2-meth­yltetra­hydro­furan (50 ml) and cooled to 0°C under a nitro­gen atmosphere. Lithium aluminium hydride (1.2 g, 32.60 mmol, 2.5 equiv.) was added portion wise over 1 h with continuous stirring. The reaction mixture was maintained at 0°C for an additional 1 h until the reduction was complete, as monitored by thin-layer chromatography (TLC). The excess lithium aluminium hydride was carefully quenched with saturated aqueous potassium sodium tartrate solution, followed by the addition of ethyl acetate. The reaction mixture was allowed to warm to room temperature, and the organic layer was separated, washed with saturated potassium sodium tartrate solution and brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to afford crude (5-cyclo­propyl-1-tosyl-1H-indol-2-yl)methanol, which was used directly in the subsequent oxidation step without further purification. The crude alcohol (3.5 g, 10.26 mmol) was dissolved in di­chloro­methane (35 ml) and cooled to 0°C. Dess–Martin periodinane (8.7 g, 20.52 mmol, 2.0 equiv.) was added portionwise over 30 min, and the reaction mixture was stirred at 0°C for 3 h. Upon completion of the reaction (TLC), the precipitated by-product was removed by filtration, and the filtrate was concentrated under reduced pressure. The residue was purified by silica-gel column chromatography to afford the title compound, 5-cyclo­propyl-1-[(4-methyl­benzene)­sulfon­yl]indole-2-carbaldehyde, as a white solid in 92% yield (3.2 g). Crystals suitable for single-crystal X-ray diffraction analysis were obtained by slow evaporation of an ethyl acetate/hexane (9:1 v/v) solution of the purified compound at room temperature over several days..

Refinement

Crystal data, data collection, and structure refinement details are given in Table 1[link].

Table 1
Experimental details

Crystal data
Chemical formula C19H17NO3S
Mr 339.39
Crystal system, space group Monoclinic, P21/c
Temperature (K) 273
a, b, c (Å) 9.9586 (4), 21.0209 (9), 7.9204 (3)
β (°) 99.126 (2)
V (Å3) 1637.06 (11)
Z 4
Radiation type Mo Kα
μ (mm−1) 0.22
Crystal size (mm) 0.32 × 0.06 × 0.05
 
Data collection
Diffractometer Bruker D8 Quest ECO
Absorption correction Multi-scan (SADABS; Krause et al., 2015View full citation)
Tmin, Tmax 0.680, 0.746
No. of measured, independent and observed [I > 2σ(I)] reflections 83410, 4049, 2668
Rint 0.064
(sin θ/λ)max (Å−1) 0.668
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.065, 0.184, 1.06
No. of reflections 4049
No. of parameters 218
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.41, −0.23
Computer programs: APEX4 and SAINT (Bruker, 2016View full citation), SHELXT2018/2 (Sheldrick, 2015aView full citation), SHELXL (Sheldrick, 2015bView full citation) and OLEX2 (Dolomanov et al., 2009View full citation).

Structural data


Computing details top

5-Cyclopropyl-1-[(4-methylbenzene)sulfonyl]indole-2-carbaldehyde top
Crystal data top
C19H17NO3SF(000) = 712
Mr = 339.39Dx = 1.377 Mg m−3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 9.9586 (4) ÅCell parameters from 9880 reflections
b = 21.0209 (9) Åθ = 2.3–23.3°
c = 7.9204 (3) ŵ = 0.22 mm−1
β = 99.126 (2)°T = 273 K
V = 1637.06 (11) Å3Needle, colourless
Z = 40.32 × 0.06 × 0.05 mm
Data collection top
Bruker D8 Quest ECO
diffractometer
2668 reflections with I > 2σ(I)
ω scansRint = 0.064
Absorption correction: multi-scan
(SADABS; Krause et al., 2015)
θmax = 28.3°, θmin = 2.8°
Tmin = 0.680, Tmax = 0.746h = −13→13
83410 measured reflectionsk = −27→27
4049 independent reflectionsl = −10→10
Refinement top
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.065H-atom parameters constrained
wR(F2) = 0.184 w = 1/[σ2(Fo2) + (0.0656P)2 + 1.6942P]
where P = (Fo2 + 2Fc2)/3
S = 1.06(Δ/σ)max < 0.001
4049 reflectionsΔρmax = 0.41 e Å−3
218 parametersΔρmin = −0.23 e Å−3
Special details top

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Refinement. The structure was solved by direct methods and refined by full-matrix least-squares on (F^2). All non-hydrogen atoms were refined with anisotropic displacement parameters. Hydrogen atoms were placed in calculated positions and refined using a riding model.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
S10.34851 (8)0.64905 (4)0.12355 (9)0.0496 (2)
O10.2746 (3)0.59482 (11)0.0534 (3)0.0642 (6)
O20.4513 (2)0.67646 (12)0.0409 (3)0.0647 (6)
O30.7097 (3)0.73354 (14)0.4654 (4)0.0819 (8)
N10.4263 (2)0.62609 (12)0.3185 (3)0.0488 (6)
C10.1366 (5)0.4586 (2)0.8626 (6)0.0876 (13)
H1A0.0656430.4795330.7838520.105*
H1B0.1233790.4590310.9813230.105*
C20.2763 (4)0.46231 (19)0.8264 (5)0.0709 (10)
H20.3450810.4627440.9297070.085*
C30.3137 (3)0.50271 (15)0.6843 (4)0.0534 (8)
C40.2355 (3)0.50178 (15)0.5196 (5)0.0581 (8)
H40.1613960.4743630.4991900.070*
C50.2635 (3)0.53947 (15)0.3878 (4)0.0554 (8)
H50.2109140.5373310.2798710.066*
C60.3733 (3)0.58092 (13)0.4215 (4)0.0452 (7)
C70.2339 (3)0.70821 (14)0.1642 (3)0.0434 (6)
C80.2692 (3)0.77164 (15)0.1546 (4)0.0527 (8)
H80.3533570.7830460.1271500.063*
C90.1777 (3)0.81772 (15)0.1863 (4)0.0560 (8)
H90.2005720.8603740.1781690.067*
C100.0530 (3)0.80202 (15)0.2298 (4)0.0501 (7)
C11−0.0452 (4)0.85274 (18)0.2633 (5)0.0729 (10)
H11A0.0039420.8906430.3022040.109*
H11B−0.0959840.8383290.3494310.109*
H11C−0.1065340.8617290.1598510.109*
C120.4228 (3)0.54307 (16)0.7145 (4)0.0537 (8)
H120.4769770.5438700.8215080.064*
C130.4530 (3)0.58307 (14)0.5844 (4)0.0459 (7)
C140.5534 (3)0.63084 (16)0.5795 (4)0.0516 (7)
H140.6202620.6421390.6702450.062*
C150.5361 (3)0.65718 (14)0.4221 (4)0.0477 (7)
C160.6178 (3)0.70994 (17)0.3694 (5)0.0623 (9)
H160.5974200.7254220.2582650.075*
C170.2027 (4)0.40283 (19)0.8008 (6)0.0802 (12)
H17A0.2298130.3686770.8813510.096*
H17B0.1721290.3891610.6840550.096*
C180.1090 (3)0.69125 (15)0.2069 (4)0.0538 (8)
H180.0854920.6486080.2133290.065*
C190.0200 (3)0.73828 (16)0.2397 (5)0.0570 (8)
H19−0.0635680.7269650.2689570.068*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
S10.0553 (5)0.0524 (5)0.0420 (4)0.0031 (3)0.0110 (3)−0.0025 (3)
O10.0828 (17)0.0564 (14)0.0514 (13)−0.0019 (12)0.0040 (12)−0.0114 (11)
O20.0645 (14)0.0806 (16)0.0544 (13)0.0058 (12)0.0261 (11)0.0075 (12)
O30.0610 (15)0.0894 (19)0.095 (2)−0.0249 (15)0.0098 (14)−0.0019 (16)
N10.0475 (14)0.0501 (14)0.0489 (14)−0.0005 (11)0.0076 (11)0.0024 (11)
C10.096 (3)0.070 (3)0.110 (3)−0.005 (2)0.056 (3)0.005 (2)
C20.073 (2)0.073 (2)0.067 (2)−0.009 (2)0.0125 (19)0.0067 (19)
C30.0576 (19)0.0488 (17)0.0557 (18)0.0072 (14)0.0145 (15)0.0011 (14)
C40.0556 (19)0.0484 (17)0.072 (2)−0.0089 (15)0.0136 (16)−0.0055 (16)
C50.0571 (19)0.0522 (18)0.0548 (18)−0.0033 (15)0.0028 (15)−0.0014 (15)
C60.0446 (15)0.0412 (15)0.0506 (16)0.0060 (12)0.0104 (13)−0.0029 (12)
C70.0435 (15)0.0478 (16)0.0381 (14)−0.0008 (13)0.0038 (11)0.0004 (12)
C80.0483 (17)0.0512 (17)0.0603 (19)−0.0093 (14)0.0140 (14)0.0033 (14)
C90.0591 (19)0.0427 (17)0.066 (2)−0.0051 (14)0.0088 (16)0.0034 (14)
C100.0479 (16)0.0542 (18)0.0459 (16)0.0042 (14)0.0007 (13)−0.0024 (13)
C110.063 (2)0.069 (2)0.086 (3)0.0138 (18)0.0095 (19)−0.007 (2)
C120.0467 (16)0.0608 (19)0.0535 (18)0.0041 (15)0.0073 (14)0.0036 (15)
C130.0384 (15)0.0511 (16)0.0494 (16)0.0096 (12)0.0105 (12)−0.0016 (13)
C140.0362 (14)0.0627 (19)0.0552 (18)0.0026 (14)0.0049 (13)−0.0035 (15)
C150.0376 (15)0.0506 (17)0.0557 (17)0.0064 (13)0.0100 (13)−0.0019 (14)
C160.0531 (19)0.065 (2)0.070 (2)−0.0043 (17)0.0148 (17)0.0002 (18)
C170.097 (3)0.058 (2)0.093 (3)−0.006 (2)0.039 (2)0.003 (2)
C180.0489 (17)0.0434 (16)0.070 (2)−0.0089 (13)0.0128 (15)0.0018 (15)
C190.0381 (15)0.060 (2)0.073 (2)−0.0063 (14)0.0110 (15)0.0036 (16)
Geometric parameters (Å, º) top
S1—O11.421 (2)C7—C181.386 (4)
S1—O21.422 (2)C8—H80.9300
S1—N11.684 (3)C8—C91.380 (4)
S1—C71.752 (3)C9—H90.9300
O3—C161.201 (4)C9—C101.380 (4)
N1—C61.409 (4)C10—C111.499 (5)
N1—C151.418 (4)C10—C191.385 (4)
C1—H1A0.9700C11—H11A0.9600
C1—H1B0.9700C11—H11B0.9600
C1—C21.467 (5)C11—H11C0.9600
C1—C171.467 (6)C12—H120.9300
C2—H20.9800C12—C131.399 (4)
C2—C31.503 (5)C13—C141.422 (4)
C2—C171.447 (5)C14—H140.9300
C3—C41.409 (5)C14—C151.350 (4)
C3—C121.370 (5)C15—C161.474 (5)
C4—H40.9300C16—H160.9300
C4—C51.374 (5)C17—H17A0.9700
C5—H50.9300C17—H17B0.9700
C5—C61.390 (4)C18—H180.9300
C6—C131.404 (4)C18—C191.380 (4)
C7—C81.384 (4)C19—H190.9300
O1—S1—O2120.73 (15)C8—C9—H9119.2
O1—S1—N1105.26 (14)C8—C9—C10121.6 (3)
O1—S1—C7109.21 (14)C10—C9—H9119.2
O2—S1—N1106.15 (14)C9—C10—C11120.8 (3)
O2—S1—C7109.53 (15)C9—C10—C19118.4 (3)
N1—S1—C7104.68 (13)C19—C10—C11120.8 (3)
C6—N1—S1124.3 (2)C10—C11—H11A109.5
C6—N1—C15107.5 (2)C10—C11—H11B109.5
C15—N1—S1126.8 (2)C10—C11—H11C109.5
H1A—C1—H1B115.0H11A—C11—H11B109.5
C2—C1—H1A117.9H11A—C11—H11C109.5
C2—C1—H1B117.9H11B—C11—H11C109.5
C2—C1—C1759.1 (3)C3—C12—H12120.0
C17—C1—H1A117.9C3—C12—C13120.1 (3)
C17—C1—H1B117.9C13—C12—H12120.0
C1—C2—H2113.4C6—C13—C14107.2 (3)
C1—C2—C3122.1 (4)C12—C13—C6120.1 (3)
C3—C2—H2113.4C12—C13—C14132.8 (3)
C17—C2—C160.4 (3)C13—C14—H14125.4
C17—C2—H2113.4C15—C14—C13109.1 (3)
C17—C2—C3124.3 (4)C15—C14—H14125.4
C4—C3—C2121.3 (3)N1—C15—C16126.3 (3)
C12—C3—C2120.2 (3)C14—C15—N1108.6 (3)
C12—C3—C4118.4 (3)C14—C15—C16125.1 (3)
C3—C4—H4118.4O3—C16—C15122.1 (4)
C5—C4—C3123.1 (3)O3—C16—H16119.0
C5—C4—H4118.4C15—C16—H16119.0
C4—C5—H5121.2C1—C17—H17A117.7
C4—C5—C6117.6 (3)C1—C17—H17B117.7
C6—C5—H5121.2C2—C17—C160.4 (3)
C5—C6—N1131.8 (3)C2—C17—H17A117.7
C5—C6—C13120.6 (3)C2—C17—H17B117.7
C13—C6—N1107.5 (3)H17A—C17—H17B114.8
C8—C7—S1119.7 (2)C7—C18—H18120.3
C8—C7—C18120.4 (3)C19—C18—C7119.3 (3)
C18—C7—S1119.9 (2)C19—C18—H18120.3
C7—C8—H8120.5C10—C19—H19119.4
C9—C8—C7119.0 (3)C18—C19—C10121.2 (3)
C9—C8—H8120.5C18—C19—H19119.4
S1—N1—C6—C59.9 (5)C4—C5—C6—N1−178.3 (3)
S1—N1—C6—C13−169.3 (2)C4—C5—C6—C130.9 (4)
S1—N1—C15—C14169.2 (2)C5—C6—C13—C120.3 (4)
S1—N1—C15—C16−10.2 (4)C5—C6—C13—C14−178.3 (3)
S1—C7—C8—C9179.8 (2)C6—N1—C15—C142.2 (3)
S1—C7—C18—C19179.6 (3)C6—N1—C15—C16−177.1 (3)
O1—S1—N1—C6−31.3 (3)C6—C13—C14—C150.4 (3)
O1—S1—N1—C15163.8 (2)C7—S1—N1—C683.8 (3)
O1—S1—C7—C8−149.7 (2)C7—S1—N1—C15−81.1 (3)
O1—S1—C7—C1830.7 (3)C7—C8—C9—C101.0 (5)
O2—S1—N1—C6−160.3 (2)C7—C18—C19—C100.4 (5)
O2—S1—N1—C1534.8 (3)C8—C7—C18—C190.0 (5)
O2—S1—C7—C8−15.4 (3)C8—C9—C10—C11−179.8 (3)
O2—S1—C7—C18165.0 (2)C8—C9—C10—C19−0.6 (5)
N1—S1—C7—C898.0 (3)C9—C10—C19—C18−0.1 (5)
N1—S1—C7—C18−81.6 (3)C11—C10—C19—C18179.1 (3)
N1—C6—C13—C12179.7 (3)C12—C3—C4—C50.0 (5)
N1—C6—C13—C141.0 (3)C12—C13—C14—C15−178.1 (3)
N1—C15—C16—O3−179.8 (3)C13—C14—C15—N1−1.6 (3)
C1—C2—C3—C4−46.6 (5)C13—C14—C15—C16177.8 (3)
C1—C2—C3—C12131.3 (4)C14—C15—C16—O31.0 (5)
C2—C3—C4—C5177.8 (3)C15—N1—C6—C5177.3 (3)
C2—C3—C12—C13−176.6 (3)C15—N1—C6—C13−2.0 (3)
C3—C2—C17—C1−110.6 (5)C17—C1—C2—C3114.1 (4)
C3—C4—C5—C6−1.0 (5)C17—C2—C3—C427.3 (5)
C3—C12—C13—C6−1.4 (4)C17—C2—C3—C12−154.9 (4)
C3—C12—C13—C14176.8 (3)C18—C7—C8—C9−0.7 (5)
C4—C3—C12—C131.3 (5)
 

Footnotes

‡Additional corresponding author, email: [email protected].

§Additional corresponding author, email: [email protected].

Additional corresponding author, email: [email protected]

Acknowledgements

VA, KVK, and HSPR thank the management of Teadus Pharma Private Limited, Prashant Nagar, Kukatpalli, Hyderabad for the facilities and encouragement. NG, JM and NDY thank the managements of Reva University and Sharda University respectively for support and encouragement.

References

Return to citationBruker (2016). APEX4 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
Return to citationDolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341.  Web of Science CrossRef CAS IUCr Journals Google Scholar
Return to citationDrăgoi, C. M., Nicolae, A.-C. & Dumitrescu, I.-B. (2026). Targets 4, 4.  Google Scholar
Return to citationFoote, K. M., Blades, K., Cronin, A., Fillery, S., Guichard, S. S., Hassall, L., Hickson, I., Jacq, X., Jewsbury, P. J., McGuire, T. M., Nissink, J. W. M., Odedra, R., Page, K., Perkins, P., Suleman, A., Tam, K., Thommes, P., Broadhurst, R. & Wood, C. (2013). J. Med. Chem. 56, 2125–2138.  CrossRef CAS PubMed Google Scholar
Return to citationGribble, G. W. (2016). Indole Ring Synthesis: From Natural Products to Drug Discovery. Chichester: John Wiley & Sons.  Google Scholar
Return to citationHassam, M., Basson, A. E., Liotta, D. C., Morris, L., van Otterlo, W. A. L. & Pelly, S. C. (2012). ACS Med. Chem. Lett. 3, 470–475.  Web of Science CrossRef CAS PubMed Google Scholar
Return to citationKrause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst. 48, 3–10.  Web of Science CSD CrossRef ICSD CAS IUCr Journals Google Scholar
Return to citationKumar, P., Ahma, M. I., Singh, S., Pratam, M. R. F. & Mishra, A. K. (2022). Thai J. Pharm. Sci. 46, 233–250.  CrossRef CAS Google Scholar
Return to citationPradeep, P., Khorasani, S., de Koning, C. B. & Fernandes, M. A. (2013). Acta Cryst. E69, o219.  CrossRef IUCr Journals Google Scholar
Return to citationSheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
Return to citationSheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
Return to citationSravanthi, T. V. & Manju, S. L. (2016). Eur. J. Pharm. Sci. 91, 1–10.  Web of Science CrossRef CAS PubMed Google Scholar
Return to citationSundberg, R. J. (2012). The Chemistry of Indoles. Vol. 18. Amsterdam: Elsevier.  Google Scholar
Return to citationTran, T. N. & Henary, M. (2022). Molecules 27, 2700.  CrossRef PubMed Google Scholar
Return to citationWorld Intellectual Property Organization (2011). WO 2011016528, A1. Chugai Seiyaku Kabushiki Kaisha & F. Hoffmann-La Roche AG.  Google Scholar
Return to citationYang, T., Zhang, Y., Liu, P., Qi, P., Li, X., Zhi, W. & Zhao, L. (2026). J. Enzyme Inhib. Med. Chem. 41, 2616556.  CrossRef PubMed Google Scholar
Return to citationZeng, W., Han, C., Mohammed, S., Li, S., Song, Y., Sun, F. & Du, Y. (2024). Med. Chem. 15, 788–808.  CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoIUCrDATA
ISSN: 2414-3146